MSP Recovery, Inc. 8-K: Warrant Exercise Details
Ticker: MSPRZ · Form: 8-K · Filed: Aug 26, 2025 · CIK: 1802450
| Field | Detail |
|---|---|
| Company | Msp Recovery, INC. (MSPRZ) |
| Form Type | 8-K |
| Filed Date | Aug 26, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001, $7,187.50, $0.0625, $12.7 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: warrants, disclosure, securities
TL;DR
MSP Recovery warrants exercisable for Class A common stock at $0.25 each.
AI Summary
On August 20, 2025, MSP Recovery, Inc. filed an 8-K report detailing events related to its redeemable warrants. The filing specifies that each whole warrant is exercisable for one share of Class A Common Stock at an exercise price of $0.25 per share.
Why It Matters
This filing clarifies the terms under which MSP Recovery's warrants can be exercised, which is crucial information for warrant holders and potential investors.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of warrant terms and does not indicate new financial distress or significant operational changes.
Key Numbers
- $0.25 — Warrant Exercise Price (Price per share for Class A Common Stock)
Key Players & Entities
- MSP Recovery, Inc. (company) — Registrant
- August 20, 2025 (date) — Earliest event reported
- Class A Common Stock (security) — Stock underlying warrants
- $0.25 (dollar_amount) — Warrant exercise price
FAQ
What is the exercise price for MSP Recovery's redeemable warrants?
The exercise price for each whole warrant is $0.25 per share of Class A Common Stock.
What type of stock can be acquired by exercising the warrants?
Exercising the warrants allows for the acquisition of Class A Common Stock.
What is the earliest event date reported in this 8-K filing?
The earliest event reported is August 20, 2025.
What is the company's central index key (CIK)?
The company's CIK is 0001802450.
What is the filing date of this 8-K report?
The filing date is August 26, 2025.
Filing Stats: 1,193 words · 5 min read · ~4 pages · Grade level 13.7 · Accepted 2025-08-26 17:15:28
Key Financial Figures
- $0.0001 — hich registered Class A Common stock, $0.0001 par value per share MSPR Nasdaq Cap
- $7,187.50 — A common stock at an exercise price of $7,187.50 per share MSPRW Nasdaq Capital Mark
- $0.0625 — A common stock at an exercise price of $0.0625 per share MSPRZ Nasdaq Capital Mark
- $12.7 million — e jury awarded Plaintiffs approximately $12.7 million in damages against MSP Recovery, LLC on
Filing Documents
- mspr-20250820.htm (8-K) — 72KB
- 0001802450-25-000042.txt ( ) — 237KB
- mspr-20250820.xsd (EX-101.SCH) — 60KB
- mspr-20250820_htm.xml (XML) — 8KB
01 Other Events
Item 8.01 Other Events. Jury Verdict Against the Company's Subsidiary In the matter of Menendez v. Ruiz , Case No. 2023-001738-CA-01, pending in the Eleventh Judicial Circuit in and for Miami-Dade County, Florida (the "Menendez Litigation"), plaintiffs Norberto Menendez, iNewton, LLC, Synnova Health, Inc., and Health Beats, LLC (collectively, the "Plaintiffs") sought damages under eight legal theories against John H. Ruiz, individually, MSP Recovery, Inc. (the "Company"), and MSP Recovery, LLC, a subsidiary of the Company (together, the "Defendants"). Following a seven-day trial, on August 20, 2025, a jury returned a verdict finding no liability against the Defendants on all but one of the counts asserted in the Complaint. Specifically, the jury rejected every fraud and misrepresentation theory and completely exonerated the Company and Mr. Ruiz from any and all claims asserted against them. The jury did return a finding of breach of an alleged oral contract, but only as to the Company's subsidiary, MSP Recovery, LLC, which holds all of the assets for the Company. The jury awarded Plaintiffs approximately $12.7 million in damages against MSP Recovery, LLC on that claim. The court has not entered a final judgment in the Menendez Litigation. Defendants have asserted, and continue to assert, both procedural and substantive defenses. MSP Recovery, LLC has moved for a directed verdict and intends to vigorously pursue post-trial relief, including motions to set aside the verdict and a potential appeal to the State appellate court based on various legal theories, including that the parties' integration clause invalidates any alleged oral contract as a matter of law. Moreover, as the jury found in favor of the Company and Mr. Ruiz on the deceptive and unfair practices claim, the Company and Mr. Ruiz have a statutory right under Florida law to pursue recovery of their respective attorneys' fees; a right the Company and Mr. Ruiz fully intend to pursue. Neither the Comp
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 104 Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document). (di)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MSP R ECOVERY , I NC . Dated: August 26, 2025 By: /s/ John H. Ruiz Name: John H. Ruiz Title: Chief Executive Officer